olmesartan has been researched along with Microscopic Colitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Heinrich, C; Zimmer, V | 1 |
Herman, ML; Kelly, DG; Ludvigsson, JF; Mangan, TF; Murray, JA; Rubio-Tapia, A; Wu, TT | 1 |
2 other study(ies) available for olmesartan and Microscopic Colitis
Article | Year |
---|---|
Olmesartan-induced lymphocytic colitis: a specific gap in the guideline?
Topics: Antihypertensive Agents; Biopsy; Colitis, Lymphocytic; Colitis, Microscopic; Colonoscopy; Diarrhea; Humans; Imidazoles; Practice Guidelines as Topic; Tetrazoles | 2021 |
Severe spruelike enteropathy associated with olmesartan.
Topics: Abdominal Pain; Aged; Aged, 80 and over; Anemia; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Colitis, Microscopic; Collagen; Diarrhea; Fatigue; Female; Gastritis; Hospitalization; Humans; Hypoalbuminemia; Imidazoles; Inflammation; Intestinal Mucosa; Intestines; Lymphocytes; Male; Middle Aged; Nausea; Severity of Illness Index; Stomach; Tetrazoles; Vomiting; Water-Electrolyte Imbalance; Weight Loss; Zinc | 2012 |